Clinical Trials Logo

Clinical Trial Summary

To establish the IV access strategy for terminally ill cancer patients, using comparisons of the safety, efficacy, and patient-perceived satisfaction between the initially routine PICC insertion group (routine PICC group) and general IV access group (optional PICC group).


Clinical Trial Description

Reliable intravenous (IV) access is an important issue in terminally ill cancer patients, however, they have limited or no peripheral venous access due to edema or long period of IV therapy. Thus, intravenous access has been provided by Central venous catheter (CVC).

There are some options for applying CVC in cancer patients; subclavian venous catheter (SVC), chemo-port (CP), and the peripherally inserted central catheter (PICC).

When considering the characteristics of terminally ill cancer patients, such as poor general condition and a limited period of survival, PICC could be a safe and effective method for intravenous access.

There are two previous studies concerned about PICC study in terminally ill cancer patients. They showed that PICC might be overall safe and efficient in terminally ill cancer patients. However, these studies did not evaluate superiority of PICC insertion compared to no insertion and the appropriate time for PICC insertion due to limitation of their design, such as retrospective or single-arm observational study. Thus, strategies of PICC insertion for IV access in terminally ill cancer patients have not been determined until now.

Considering the favorable results of PICC insertion in previous studies and limited survival time of terminally ill cancer patients, the investigator postulated that routine PICC insertion at the time of admission for terminal care would be effective for IV access.

Thus, the investigator assumed that initially routine PICC insertion would be non-inferior in maintenance success rate / and complication rate compared to general IV access. In addition, it would be superior in patient-perceived satisfaction. The inveistigator will undertake a randomized phase II study to confirm the hypothesis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03299868
Study type Interventional
Source Pusan National University Yangsan Hospital
Contact
Status Completed
Phase Phase 2
Start date May 1, 2017
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04875988 - Point of Care UltraSound (POCUS) Use for Intravenous Catheter Placement During Pediatric Interfacility Transport N/A
Completed NCT03029754 - Effect of Passive Leg Raise for Pediatric Peripheral IV Placement N/A
Enrolling by invitation NCT05204082 - A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children N/A
Completed NCT04135547 - Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest N/A
Completed NCT05695183 - IV SafeLock Device Functionality in Emergency Department N/A
Completed NCT02469038 - Ultrasound-Guided Peripheral Venous Access Using AccuCath N/A
Completed NCT04190407 - Intravenous Access Time in Pediatric Patients N/A